Fusidic Acid BP Impurity L Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

9,11-Anhydro Fusidic Acid is a co-metabolite of Fusidic Acid (F865500).

Fusidic Acid BP Impurity L Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Fusidic Acid BP Impurity L Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Guangzhou PI PI BIOTECH INC	+86-86-020-81716320 +8613602409664	Sales@pipitech.com	China	973	55
Standardpharm Co. Ltd.	86-714-3992388	overseasales1@yongstandards.com	United States	14332	58
sgtlifesciences pvt ltd	+8617013299288	dj@sgtlifesciences.com	China	12373	58
Moxin Chemicals	+86-17320513646 +8617320513646	anna@molcoo.com	China	10000	58
Sinco Pharmachem (ShenZhen) R&D Co., Ltd.	+undefined18603013401	jack.lin@sincopharmachem.com	China	10000	58
QUALITY CONTROL SOLUTIONS LTD.	+86-0755-66853366 +8613670046396	export03@qcsrm.com	China	24342	58
LangFangshi Zekang Pharma Tech CO.,Itd.	0316-2883536 19333636468	93618484@qq.com	China	2585	58
J & K SCIENTIFIC LTD.	18210857532; 18210857532	jkinfo@jkchemical.com	China	96815	76
Chemsky (shanghai) International Co.,Ltd	021-50135380	shchemsky@sina.com	China	15402	60
BOC Sciences	1-631-485-4226; 16314854226	info@bocsci.com	United States	9920	65

74048-41-2()Verwandte Suche:

---

• (8α,13α,14β,17Z)-16β-Acetoxy-3α-hydroxy-9,11-didehydro-29-nor-5α-dammara-17(20),24-dien-21-oic acid
• 9,11-Anhydrofusidic acid
• (3α,4α,8α,13α,14β,16β,17Z)-16-(Acetyloxy)-3-hydroxy-29-nordaMMara-9(11),17(20),24-trien-21-oic Acid
• Sodium Fusidate EP Impurity L
• Fusidic Acid EP Impurity L
• Sodium Fusidate Impurity 12（Sodium Fusidate EP Impurity L）
• Fusidic Acid Impurity L(EP)
• (2Z)-2-[(3R,4S,5S,8R,10S,13R,14S,16R)-16-acetyloxy-3-hydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,12,13,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoic acid
• Fusidic Acid Impurity L
• Fusidic Acid BP Impurity?L
• Fusidic Acid Impurity L(EP),9,11-anhydrofusidic acid
• 29-Nordammara-9(11),17(20),24-trien-21-oic acid, 16-(acetyloxy)-3-hydroxy-, (3α,4α,8α,13α,14β,16β,17Z)- (9CI)
• (Z)-2-((3R,4S,5S,8R,10S,13R,14S,16S)-16-acetoxy-3-hydroxy-4,8,10,14-tetramethyl-3,4,5,6,7,8,12,13,15,16-decahydro-1H-cyclopenta[a]phenanthren-17(2H,10H,14H)-ylidene)-6-methylhept-5-enoic acid
• Fusidic Acid EP Impurity L (Sodium Fusidate EP Impurity L/ 9,11-Anhydro Fusidic Acid)
• Ent-(17Z)-16α-(acetyloxy)-3β-hydroxy-4β,8,14-trimethyl-18-nor-5β,10α-cholesta-9(11),17(20),24-trien-21-oic acid (9,11-anhydrofusidic acid)
• 29-Nordammara-9(11),17(20),24-trien-21-oic acid, 16-(acetyloxy)-3-hydroxy-, (3α,4α,8α,13α,14β,16β,17Z)- (Sodium Fusidate Impurity)
• Fusidic Acid EP Impurity L（ Sodium Fusidate EP Impurity L）
• Sodium Fusidate Impurity L
• 74048-41-2
• Intermediates & Fine Chemicals
• Metabolites & Impurties
• Pharmaceuticals
• Steroids